Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Okra and Reduced Fasting Blood Glucose Levels

Research synthesisLow evidenceModerate effect3 studies · 3 beneficial · 0 neutral · 0 harmful

Across 3 studies, all reported beneficial moderate-to-large effects of okra on reducing fasting blood glucose levels in individuals with prediabetes or type 2 diabetes. The most-studied dose is up to 3,000 mg/day, and the evidence is derived from systematic reviews and meta-analyses. However, the evidence base is small, and conclusions should be considered preliminary.

  • Effective dose range: ≤3000 mg/day
  • Studied populations: individuals with prediabetes or type 2 diabetes

Caveats: Evidence base is small (only 3 studies) — conclusions should be considered preliminary. Available evidence is overwhelmingly positive — clinical literature in this area is subject to publication bias (null-result studies are less likely to be published or indexed).

Generated Jul 11, 2026
Doses used in studies
  • mg/day: 3,000 (median 3,000, IQR 3,0003,000) 1 study
3 of 3 papers
Back to top